Trial intelligence / Profile preview

Maternal HAART to Prevent HIV Transmission in Breastfeeding

NCT00146380Phase 2Completed

Sponsor
Centers for Disease Control and Prevention
Start
Jul 2003
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zidovudine, lamivudine, nevirapine, nelfinavir in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Started Jul 2003; status: completed.

02

Drugs

zidovudinelamivudinenevirapinenelfinavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00146380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00146380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call